Somatostatin Receptor-Based Molecular Imaging and Therapy for Neuroendocrine Tumors

Table 1

Characteristics of radionuclides used for SRI and PRRT.

Radionuclide	Type of decay	Type of rays	Half-life	Energy	Producer
^111In	EC	𝛾	2.8 days	173 KeV	^111Cd (p, n)
				247 KeV
^18F	β+	𝛽	109.8 min	511 KeV	^20Ne (d, 𝛼)
	EC				^18O (p, n)
^68Ga	β+	𝛽	68.3 min	511 KeV	^68Ge-^68Ga generator
^90Y	β−	𝛽	64 h	2.288 MeV	^90Sr-^90Y generator
^177Lu	β−	𝛽	6.7 days	0.5 MeV	^176Lu (n, γ)
					^176Yb (n, γ)
^64Cu	β−	𝛽	12.7 h	0.58 MeV	^63Cu (n, γ)
	β+			0.653 MeV	^64Zn (n, p)
	EC	𝛾		1.346 MeV